Abstract:Hyaluronic acid (HA), naturally present in healthy joints, is degraded in arthritic conditions due to various factors. Traditional methods of administering HA via injection, topical application, or oral intake face challenges related to stability, bioavailability, pharmacokinetics, and potential adverse effects. However, when HA is delivered using nanoscaffolds such as micelles, liposomes, hydrogels, solid‐lipid NPs, biliosomes, polymer NPs, or hydroxyapatite NPs, these issues can be mitigated. This innovative approach enhances the effectiveness of HA, advancing the treatment of arthritis. Arthritis is a significant health concern affecting over 528 million people globally, reducing quality of life. The chronic nature of arthritis, coupled with insufficient therapeutic effectiveness, recurrence, and adverse side effects, complicates its management. Hyaluronic acid (HA) has emerged as a promising solution due to its biocompatibility, non‐toxicity, and targeted drug delivery capabilities, being a key component of the cartilage extracellular matrix widely used in managing arthritis. HA's inherent viscoelastic property and ability to target CD44 have spurred interest in developing HA‐based systems for delivering drugs to manage arthritis. Hyaluronic acid nanoscaffolds (HA‐NSCfs) show improved outcomes over treatments, including enhanced drug uptake through receptor‐mediated targeting, prolonged retention in the synovium, reduced proinflammatory mediator expression, enhanced cartilage regeneration, reduced drug toxicity due to sustained release, and more cost‐effective treatments. This review highlights the rationale for using HA‐NSCfs for the management and advanced drug delivery systems in arthritis, emphasizing preclinical and clinical results. It discusses various solid‐lipid nanoparticles, hydroxyapatite nanoparticles, polyelectrolyte complexes, liposomes, bilosomes, drug‐polymer conjugates, hydrogels, inorganic nanoparticles, and polymer nanoparticles, etc reported for arthritis management. Additionally, the review identifies key challenges and offers suggestions to address them, ultimately highlighting the potential of HA‐NSCfs as a topical treatment for arthritis.

Nitric Oxide-Scavenging Hyaluronic Acid Nanoparticles for Osteoarthritis Treatment

Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment

Nanozyme-enhanced injectable hyaluronic acid-based hydrogel for the treatment of osteoarthritis

Reactive Oxygen Species-Scavenging Nanoparticles Coated with Chondroitin Sulfate Protect Cartilage Against Osteoarthritis in Vivo

Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis

Nordihydroguaiaretic acid microparticles are effective in the treatment of osteoarthritis

Recent Advancements of Hyaluronic Acid Nanoscaffolds in Arthritis Management

Sustained therapeutic effects of self-assembled hyaluronic acid nanoparticles loaded with α-Ketoglutarate in various osteoarthritis stages

Biomimetic NO Scavenging Hyaluronic Acid Nanoparticles Enable Targeted Delivery of MTX and Integrated Management of Rheumatoid Arthritis

A Composite Nanomaterial with the Ability to Regulate Oxidative Stress and Anti‐inflammatory for the Treatment of Osteoarthritis

Nanotherapy in Joints: Increasing Endogenous Hyaluronan Production by Delivering Hyaluronan Synthase 2

A neutrophil cell membrane-biomimetic nanoplatform based on L-arginine nanoparticles for early osteoarthritis diagnosis and nitric oxide therapy

Nitidine Chloride Alleviates Inflammation and Cellular Senescence in Murine Osteoarthritis Through Scavenging ROS

Effects of a Combination of Polynucleotide and Hyaluronic Acid for Treating Osteoarthritis

Sustained intra-articular reactive oxygen species scavenging and alleviation of osteoarthritis by biocompatible amino-modified tantalum nanoparticles

Injectable Ozone-Rich Nanocomposite Hydrogel Loaded with D-Mannose for Anti-Inflammatory and Cartilage Protection in Osteoarthritis Treatment

Development and functional evaluation of a hyaluronic acid coated nano-formulation with kaempferol as a novel intra-articular agent for Knee Osteoarthritis treatment

Self-Assembled Nanospheres with Enhanced Interfacial Lubrication for the Treatment of Osteoarthritis

The Novel Hyaluronic Acid Granular Hydrogel Attenuates Osteoarthritis Progression by Inhibiting the TLR‐2/NF‐κB Signaling Pathway Through Suppressing Cellular Senescence

NIR-driven Polydopamine-Based Nanoenzymes As ROS Scavengers to Suppress Osteoarthritis Progression

Hyaluronan-Loaded Liposomal Dexamethasone–Diclofenac Nanoparticles for Local Osteoarthritis Treatment